Intraoperative Neuromonitoring Market Future Prospects
The global intraoperative neuromonitoring market size is USD 3,658.4 million in 2024, and this number is expected to increase to USD 5,635.1 million by 2032, advancing at a CAGR of 5.7% during the forecast period (2025–2032).
This is attributed to the growing prevalence of numerous lifestyle-related chronic diseases such as cardiovascular and neurological conditions, the increasing focus on patient safety during complex and difficult surgeries, and the mounting demand for minimally invasive and advanced intraoperative neuromonitoring devices. Moreover, the high R&D spending by industry giants and various government policies support the market growth.
The geriatric population is at an increased risk of having various diseases. The increasing life expectancy and falling birth rate are the major causes of the growing aging population. As per the WHO, by 2030, 1.4 billion people around the world will be aged 60 years or more.
As age increases, the population is more likely to encounter various chronic diseases such as cardiovascular disease, neuropathic disorders, old age-related trauma, osteoarthritis, and related orthopedic disorders.
Moreover, the risk of developing spinal disorders such as lower back pain increases with age, due to the deterioration of the intervertebral discs in older people. Most of the aforementioned chronic abnormalities are treated with the help of surgical intervention. As neuromonitoring is an important part of surgeries that are associated with the nervous system, the rapidly aging population and favorable demographics across the globe would drive the demand for IONM procedures.